The following are reports and data pertinent to the field of contamination control in the healthcare industry with emphasis on hospital acquired infections and antibiotic resistant infections.
American Infection Control Study
Effectiveness of a novel ozone-based system for the rapid high-level disinfection of health care spaces and surfacesby Dick Zoutman, MD, FRCPC, Michael Shannon, MD, MSc,b,c and Arkady Mandel, MD, PhD, DScc
CDC ANTIBIOTIC RESISTANCE THREATS
in the United States, 2013
Excerpt from the FOREWORD
When first-line and then second-line antibiotic treatment options are limited by resistance or are unavailable, healthcare providers are forced to use antibiotics that may be more toxic to the patient and frequently more expensive and less effective. Even when alternative treatments exist, research has shown that patients with resistant infections are often much more likely to die, and survivors have significantly longer hospital stays, delayed recuperation, and long-term disability. Efforts to prevent such threats build on the foundation of proven public health strategies: immunization, infection control, protecting the food supply, antibiotic stewardship, and reducing person-to-person spread through screening, treatment and education.
C3 Contamination Control Corporation Presentation
Today in North America a person dies every 5 minutes from largely preventable hospital acquired infections (HAIs). This silent epidemic kills an estimated 100,000 Americans every year(CDC) and an additional 8,000 – 10,000 in Canada. This problem has been developing for two decades
Preliminary Test Results Belleville Hospital
Lists CFU before and after AsepticSure™ treatment on multiple surfaces.
C3 Contamination Control Corporation Onsite Disinfection Brochure
Even after using modern cleaning methods, you can never be 100% certain all infectious pathogens have been eradicated.
We can get you to 99.9999%.